Pizao PE - Search Results

1

Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.

Pizao PE, Lyaruu DM, Peters GJ, van Ark-Otte J, Winograd B, Giaccone G, Pinedo HM. Pizao PE, et al. Br J Cancer. 1992 Oct;66(4):660-5. doi: 10.1038/bjc.1992.333. Br J Cancer. 1992. PMID: 1419603 Free PMC article.

2

In vitro chemosensitivity testing of multilayered microcultures.

Pizao PE, Winograd B, Peters GJ, Leyva A, Giaccone G, Pinedo HM. Pizao PE, et al. Anticancer Res. 1992 Jul-Aug;12(4):1319-22. Anticancer Res. 1992. PMID: 1503428

3

The effect of schedule, protein binding and growth factors on the activity of suramin.

Lopez Lopez R, Peters GJ, van Loenen AC, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM. Lopez Lopez R, et al. Among authors: pizao pe. Int J Cancer. 1992 Jul 30;51(6):921-6. doi: 10.1002/ijc.2910510615. Int J Cancer. 1992. PMID: 1639540

4

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.

Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Keepers YP, et al. Among authors: pizao pe. Eur J Cancer. 1991;27(7):897-900. doi: 10.1016/0277-5379(91)90142-z. Eur J Cancer. 1991. PMID: 1834124

5

Antiproliferative activity of the topoisomerase I inhibitors topotecan and camptothecin, on sub- and postconfluent tumor cell cultures.

Pizao PE, Smitskamp-Wilms E, Van Ark-Otte J, Beijnen JH, Peters GJ, Pinedo HM, Giaccone G. Pizao PE, et al. Biochem Pharmacol. 1994 Sep 15;48(6):1145-54. doi: 10.1016/0006-2952(94)90151-1. Biochem Pharmacol. 1994. PMID: 7945408

6

Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures.

Pizao PE, Peters GJ, Van Ark-Otte J, Smets LA, Smitskamp-Wilms E, Winograd B, Pinedo HM, Giaccone G. Pizao PE, et al. Eur J Cancer. 1993;29A(11):1566-73. doi: 10.1016/0959-8049(93)90296-r. Eur J Cancer. 1993. PMID: 8217364

7

In-vitro schedule-dependency of eo9 and miltefosine in comparison to standard drugs in colon-cancer cells.

Vanarkotte J, Peters G, Pizao P, Keepers Y, Giaccone G. Vanarkotte J, et al. Int J Oncol. 1994 Mar;4(3):709-15. doi: 10.3892/ijo.4.3.709. Int J Oncol. 1994. PMID: 21566981

8

Effect of suramin on adenylate cyclase and protein kinase C.

Lopez-Lopez R, Langeveld CH, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM, Peters GJ. Lopez-Lopez R, et al. Among authors: pizao pe. Anticancer Drug Des. 1994 Aug;9(4):279-90. Anticancer Drug Des. 1994. PMID: 7916897

9

The multilayered postconfluent cell culture as a model for drug screening.

Padrón JM, van der Wilt CL, Smid K, Smitskamp-Wilms E, Backus HH, Pizao PE, Giaccone G, Peters GJ. Padrón JM, et al. Among authors: pizao pe. Crit Rev Oncol Hematol. 2000 Nov-Dec;36(2-3):141-57. doi: 10.1016/s1040-8428(00)00083-4. Crit Rev Oncol Hematol. 2000. PMID: 11033303 Review.

10

EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.

Hendriks HR, Pizao PE, Berger DP, Kooistra KL, Bibby MC, Boven E, Dreef-van der Meulen HC, Henrar RE, Fiebig HH, Double JA, et al. Hendriks HR, et al. Among authors: pizao pe. Eur J Cancer. 1993;29A(6):897-906. doi: 10.1016/s0959-8049(05)80434-4. Eur J Cancer. 1993. PMID: 8484984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters